The "graying" of the population has increased the number of patients with hypertension, threatening these patients' quality and length of life. The challenge for physicians treating patients with hypertension is to normalize blood pressure effectively, with as few therapeutic misadventures and medication-related symptoms as possible, at the least possible cost.
Early in the development of antihypertensive agents, it was generally assumed that comparative trials of specific antihypertensive agents were unnecessary because treatments that lowered blood pressure equally were likely to yield equal clinical benefit. This belief led to the use of blood pressure as a surrogate marker and sufficient basis for approval for labeling drugs for use as antihypertensive agents.1 However, as new drugs were developed with very different mechanisms of action and adverse event profiles, this theory began to be reevaluated. In fact, it seems likely that certain groups of patients—such as those with diabetes, left ventricular dysfunction, angina pectoris, migraine, prostatism, or lipid disorders—may reap different advantages from different antihypertensive drug groups.2 This belief, in part, led to the suggestion in the "Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" that initial antihypertensive drug choices take into account the comorbid conditions of the patients being treated.3
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Thank you for submitting a comment on this article. It will be reviewed by JAMA editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 20
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature In one very large trial, investigators randomly allocated more than 6000 subjects to receive...
Users' Guides to the Medical Literature Table 9.2-3 Refuted Evidence From Observational Studiesa
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Need assistance?
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.